133 related articles for article (PubMed ID: 36037999)
1. Clinical outcomes in patients with atrial fibrillation treated with digoxin, according to the presence of heart failure: Insights from the MISOAC-AF trial.
Botis M; Kartas A; Samaras A; Akrivos E; Vrana E; Liampas E; Papazoglou AS; Moysidis DV; Papanastasiou A; Baroutidou A; Karvounis H; Tzikas A; Parissis J; Drakos SG; Giannakoulas G
Hellenic J Cardiol; 2022; 68():25-32. PubMed ID: 36037999
[TBL] [Abstract][Full Text] [Related]
2. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
[TBL] [Abstract][Full Text] [Related]
3. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
Gheorghiade M; Fonarow GC; van Veldhuisen DJ; Cleland JG; Butler J; Epstein AE; Patel K; Aban IB; Aronow WS; Anker SD; Ahmed A
Eur Heart J; 2013 May; 34(20):1489-97. PubMed ID: 23592708
[TBL] [Abstract][Full Text] [Related]
4. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
Eisen A; Ruff CT; Braunwald E; Hamershock RA; Lewis BS; Hassager C; Chao TF; Le Heuzey JY; Mercuri M; Rutman H; Antman EM; Giugliano RP
J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28666993
[TBL] [Abstract][Full Text] [Related]
5. Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry.
Migaj J; Kałużna-Oleksy M; Nessler J; Opolski G; Crespo-Leiro MG; Maggioni AP; Grajek S; Ponikowski P; Drożdż J; Straburzyńska-Migaj E
Kardiol Pol; 2018; 76(7):1064-1072. PubMed ID: 29476617
[TBL] [Abstract][Full Text] [Related]
6. Digoxin Impact on Heart Failure Patients with Atrial Fibrillation.
Gerakaris A; Mulita F; Koniari I; Artopoulou E; Mplani V; Tsigkas G; Abo-Elseoud M; Kounis N; Velissaris D
Med Arch; 2022 Feb; 76(1):23-28. PubMed ID: 35422570
[TBL] [Abstract][Full Text] [Related]
7. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
[TBL] [Abstract][Full Text] [Related]
8. Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis.
Wang ZQ; Zhang R; Chen MT; Wang QS; Zhang Y; Huang XH; Wang J; Yan JH; Li YG
J Cardiovasc Pharmacol; 2015 Sep; 66(3):270-5. PubMed ID: 26348825
[TBL] [Abstract][Full Text] [Related]
9. Digoxin use and outcomes after myocardial infarction in patients with atrial fibrillation.
Kytö V; Saraste A; Rautava P; Tornio A
Basic Clin Pharmacol Toxicol; 2022 Jun; 130(6):655-665. PubMed ID: 35420260
[TBL] [Abstract][Full Text] [Related]
10. [The impact of digoxin on the long-term outcomes in patients with coronary artery disease and atrial fibrillation].
Qiao Y; Wang Y; Jiang CX; Li SN; Sang CH; Tang RB; Long DY; Wu JH; He L; Du X; Dong JZ; Ma CS
Zhonghua Nei Ke Za Zhi; 2021 Sep; 60(9):797-805. PubMed ID: 34445815
[No Abstract] [Full Text] [Related]
11. Digoxin, mortality, and cardiac hospitalizations in patients with atrial fibrillation and heart failure with reduced ejection fraction and atrial fibrillation: An AF-CHF analysis.
Elayi CS; Shohoudi A; Moodie E; Etaee F; Guglin M; Roy D; Khairy P;
Int J Cardiol; 2020 Aug; 313():48-54. PubMed ID: 32320783
[TBL] [Abstract][Full Text] [Related]
12. Effect of Digoxin Use Among Medicaid Enrollees With Atrial Fibrillation.
Adedinsewo D; Xu J; Agasthi P; Oderinde A; Adekeye O; Sachdeva R; Rust G; Onwuanyi A
Circ Arrhythm Electrophysiol; 2017 May; 10(5):e004573. PubMed ID: 28500174
[TBL] [Abstract][Full Text] [Related]
13. Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses.
Gazzaniga G; Menichelli D; Scaglione F; Farcomeni A; Pani A; Pastori D
Eur J Clin Pharmacol; 2023 Apr; 79(4):473-483. PubMed ID: 36872367
[TBL] [Abstract][Full Text] [Related]
14. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
[TBL] [Abstract][Full Text] [Related]
15. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study.
Turakhia MP; Santangeli P; Winkelmayer WC; Xu X; Ullal AJ; Than CT; Schmitt S; Holmes TH; Frayne SM; Phibbs CS; Yang F; Hoang DD; Ho PM; Heidenreich PA
J Am Coll Cardiol; 2014 Aug; 64(7):660-8. PubMed ID: 25125296
[TBL] [Abstract][Full Text] [Related]
16. Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry.
Kapelios CJ; Lund LH; Benson L; Dahlström U; Rosano GMC; Hauptman PJ; Savarese G
Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 8(8):756-767. PubMed ID: 34921603
[TBL] [Abstract][Full Text] [Related]
17. Increased All-Cause Mortality Associated With Digoxin Therapy in Patients With Atrial Fibrillation: An Updated Meta-Analysis.
Chen Y; Cai X; Huang W; Wu Y; Huang Y; Hu Y
Medicine (Baltimore); 2015 Dec; 94(52):e2409. PubMed ID: 26717399
[TBL] [Abstract][Full Text] [Related]
18. Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF).
Friberg L; Hammar N; Rosenqvist M
Heart; 2010 Feb; 96(4):275-80. PubMed ID: 19710030
[TBL] [Abstract][Full Text] [Related]
19. Digoxin and Mortality in Patients With Atrial Fibrillation.
Lopes RD; Rordorf R; De Ferrari GM; Leonardi S; Thomas L; Wojdyla DM; Ridefelt P; Lawrence JH; De Caterina R; Vinereanu D; Hanna M; Flaker G; Al-Khatib SM; Hohnloser SH; Alexander JH; Granger CB; Wallentin L;
J Am Coll Cardiol; 2018 Mar; 71(10):1063-1074. PubMed ID: 29519345
[TBL] [Abstract][Full Text] [Related]
20. Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort.
Allen LA; Fonarow GC; Simon DN; Thomas LE; Marzec LN; Pokorney SD; Gersh BJ; Go AS; Hylek EM; Kowey PR; Mahaffey KW; Chang P; Peterson ED; Piccini JP;
J Am Coll Cardiol; 2015 Jun; 65(25):2691-8. PubMed ID: 26112191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
